Advertisement

Profound Medical Corp. PRN.TO

Set alert

Price alert · PRN.TO

All alert types
9.38 CAD +0.20 +2.18%

As of Nov 2, 3:58 PM ET

9.20 Day range 9.84
6.99 52-week range 12.11
YTD
-12.91%
1 year
+12.20%
Open
9.24
Prev close
9.18
Mkt cap
342.75M
Vol
17.38K
Avg vol
14.37K
EPS
-1.37
P/E
0.00
Div yield
0.00%
More statistics
Low
9.20
High
9.84
Forward P/E
-8.70
Beta
0.83
Short ratio
4.32
Inst. own
35.99%
Dividend
0.00
Ex-div date
50-d avg
10.80
200-d avg
11.36
1y target
0.00

2Y chart

Chart tools
Interval

Signals (118)
NameDateAgo
SMA: BullishNov 2, 20264 hours ago
SMA: BullishOct 30, 20263 days ago
MACD: Buy SignalOct 30, 20263 days ago
MACD: Sell SignalOct 20, 20261 week ago
SMA: BearishOct 15, 20262 weeks ago
SMA: BearishOct 14, 20262 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
MACD: Buy SignalSep 28, 20261 month ago
RSI: OversoldSep 14, 20261 month ago
RSI: OversoldSep 10, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
MACD: Buy SignalSep 4, 20261 month ago
SMA: BearishAug 28, 20262 months ago
SMA: BearishAug 27, 20262 months ago
SMA: BullishAug 26, 20262 months ago
SMA: BullishAug 26, 20262 months ago
SMA: BearishAug 20, 20262 months ago
SMA: BullishAug 18, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
RSI: OverboughtAug 4, 20263 months ago
MACD: Buy SignalJul 27, 20263 months ago
SMA: BearishJul 16, 20263 months ago
MACD: Sell SignalJul 16, 20263 months ago
MACD: Buy SignalJul 2, 20264 months ago
SMA: BullishJun 26, 20264 months ago
SMA: BearishJun 25, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
SMA: BearishJun 22, 20264 months ago
SMA: BullishJun 18, 20264 months ago
MACD: Buy SignalJun 18, 20264 months ago
SMA: BearishJun 17, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BullishJun 9, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 4, 20265 months ago
SMA: BearishJun 2, 20265 months ago
MACD: Sell SignalMay 15, 20265 months ago
MACD: Buy SignalMay 5, 20266 months ago
MACD: Sell SignalApr 29, 20266 months ago
SMA: BullishApr 14, 20266 months ago
SMA: BullishApr 13, 20266 months ago
SMA: BearishApr 10, 20266 months ago
SMA: BearishApr 10, 20266 months ago
SMA: BullishApr 8, 20266 months ago
SMA: BearishApr 7, 20266 months ago
SMA: BullishApr 6, 20267 months ago
SMA: BearishApr 2, 20267 months ago
SMA: BullishApr 1, 20267 months ago
SMA: BullishMar 31, 20267 months ago
SMA: BearishMar 30, 20267 months ago
SMA: BullishMar 26, 20267 months ago
MACD: Buy SignalMar 25, 20267 months ago
SMA: BearishMar 6, 20268 months ago
MACD: Sell SignalMar 6, 20268 months ago
RSI: OversoldMar 6, 20268 months ago
SMA: BearishMar 2, 20268 months ago
SMA: BullishFeb 26, 20268 months ago
MACD: Buy SignalFeb 19, 20268 months ago
SMA: BearishFeb 3, 20269 months ago
SMA: BullishJan 30, 20269 months ago
SMA: BearishJan 29, 20269 months ago
MACD: Sell SignalJan 19, 20269 months ago
RSI: OverboughtJan 12, 20269 months ago
RSI: OverboughtJan 8, 20269 months ago
MACD: Buy SignalJan 7, 20269 months ago
MACD: Sell SignalDec 23, 202510 months ago
MACD: Buy SignalDec 3, 202511 months ago
MACD: Sell SignalDec 1, 202511 months ago
MACD: Buy SignalNov 28, 202511 months ago
MACD: Sell SignalNov 19, 202511 months ago
MACD: Buy SignalNov 11, 202511 months ago
MACD: Sell SignalNov 3, 202512 months ago
MACD: Buy SignalOct 30, 20251 year ago
SMA: BullishOct 28, 20251 year ago
SMA: BearishOct 22, 20251 year ago
SMA: BullishOct 20, 20251 year ago
MACD: Sell SignalOct 17, 20251 year ago
SMA: BearishOct 10, 20251 year ago
SMA: BullishOct 7, 20251 year ago
RSI: OverboughtOct 7, 20251 year ago
SMA: BullishSep 23, 20251 year ago
RSI: OversoldSep 17, 20251 year ago
MACD: Buy SignalSep 16, 20251 year ago
RSI: OversoldSep 4, 20251 year ago
RSI: OversoldAug 15, 20251 year ago
MACD: Sell SignalAug 13, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
SMA: BearishJul 25, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 17, 20251 year ago
MACD: Sell SignalJun 23, 20251 year ago
RSI: OverboughtJun 10, 20251 year ago
SMA: BullishMay 28, 20251 year ago
SMA: BearishMay 27, 20251 year ago
SMA: BullishMay 26, 20251 year ago
MACD: Buy SignalMay 16, 20251 year ago
MACD: Sell SignalMay 14, 20251 year ago
MACD: Buy SignalApr 22, 20251 year ago
RSI: OversoldApr 2, 20251 year ago
SMA: BearishMar 24, 20251 year ago
SMA: BullishMar 21, 20251 year ago
SMA: BearishMar 20, 20251 year ago
SMA: BullishMar 19, 20251 year ago
SMA: BearishMar 13, 20251 year ago
SMA: BullishMar 12, 20251 year ago
MACD: Sell SignalMar 10, 20251 year ago
SMA: BearishMar 7, 20251 year ago
SMA: BullishMar 3, 20251 year ago
SMA: BearishFeb 28, 20251 year ago
MACD: Buy SignalFeb 14, 20251 year ago
RSI: OversoldFeb 7, 20251 year ago
RSI: OversoldFeb 3, 20251 year ago
RSI: OversoldJan 29, 20251 year ago
MACD: Sell SignalJan 17, 20251 year ago
MACD: Buy SignalDec 31, 20241 year ago

Key statistics

Market cap
300.28M
Enterprise value
233.66M
Trailing P/E
0.00
Forward P/E
-8.70
PEG ratio
0.00
Price / sales
33.42
Price / book
7.93
EPS (TTM)
-1.92
Beta
0.83
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
8.98M
Revenue growth
63.90%
Free cash flow
-14.79M
Total cash
27.12M
Total debt
6.23M
Return on equity
-90.17%
Shares outstanding
30.03M
Short % of float
0.00%
50-day average
10.80
200-day average
11.36

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 0.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.48175.

Earnings history

Upgrades / downgrades

PRN.TO analyst upgrades and downgrades
DateFirmActionFromTo
Jul 16, 2024StifelupHoldBuy
Mar 11, 2024Alliance Global PartnersmainBuyBuy
Mar 8, 2024StifelmainHoldHold
Jan 4, 2024Alliance Global PartnersmainBuyBuy
Nov 28, 2023Stifelinit—Hold
Aug 4, 2023Raymond JamesdownStrong BuyOutperform

About Profound Medical Corp.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Sector
Healthcare
Industry
Medical Devices
Country
Canada

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on PRN.TO — it syncs with the Stock Master app.

Institution ownership

PRN.TO institution ownership
Holder% heldSharesValueReported
FIL LTD5.11%1,535,00015.35MSep 29, 2024
Gagnon Securities, LLC4.89%1,467,24714.67MSep 29, 2024
Letko, Brosseau & Associates Inc.3.99%1,198,77511.99MSep 29, 2024
Raymond James Financial Services Advisors, Inc.2.53%760,4577.60MSep 29, 2024
Timelo Investment Management Inc.2.50%751,8077.52MSep 29, 2024
Gagnon Advisors, LLC2.49%747,2267.47MSep 29, 2024

Fund ownership

PRN.TO fund ownership
Holder% heldSharesValueReported
Royce Micro-Cap Fund0.76%227,9372.28MSep 29, 2024
Royce Micro Cap Trust0.63%189,1001.89MSep 29, 2024
Royce Capital Fund-Micro-Cap Portfolio0.33%100,1631.00MSep 29, 2024
Royce Small-Cap Fund0.17%52,098520.98KSep 29, 2024
Fidelity NASDAQ Composite Index Fund0.05%14,049140.49KOct 30, 2024
Dimensional ETF Tr-Dimensional International Small Cap ETF0.00%1,18811.88KJul 30, 2024
Advertisement